中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
2期
139-140,141
,共3页
孙建涛%霍庆祥%杨金辉%张寒%魏彭涛%韩兴涛
孫建濤%霍慶祥%楊金輝%張寒%魏彭濤%韓興濤
손건도%곽경상%양금휘%장한%위팽도%한흥도
肾盂输尿管连接部梗阻%肾盂成形术%腹腔镜%经腹入路
腎盂輸尿管連接部梗阻%腎盂成形術%腹腔鏡%經腹入路
신우수뇨관련접부경조%신우성형술%복강경%경복입로
Ureteropelvic junction obstruction%Pyeloplasty%Laparoscopy%Transperitoneal
目的:探讨经腹入路腹腔镜下肾盂成形术治疗肾盂输尿管连接部梗阻(UPJO)的手术方法及临床效果。方法:回顾性分析2008年8月-2012年6月,对28例UPJO患者行经腹入路腹腔镜下离断性肾盂成形术的方法及效果。结果:28例患者均一次性手术成功,手术时间85~160 min,平均125 min;术中出血量20~60 mL,平均32 mL;术后住院时间6~9 d,平均7.2 d;术后无严重并发症发生。随访6~36个月,平均18个月,患者腰痛症状消失。本组患者术后行B超、IVU检查示肾盂输尿管连接部吻合口无梗阻;肾积水得到改善。结论:经腹入路腹腔镜下离断性肾盂成形术是治疗UPJO的安全有效的微创手术方法。
目的:探討經腹入路腹腔鏡下腎盂成形術治療腎盂輸尿管連接部梗阻(UPJO)的手術方法及臨床效果。方法:迴顧性分析2008年8月-2012年6月,對28例UPJO患者行經腹入路腹腔鏡下離斷性腎盂成形術的方法及效果。結果:28例患者均一次性手術成功,手術時間85~160 min,平均125 min;術中齣血量20~60 mL,平均32 mL;術後住院時間6~9 d,平均7.2 d;術後無嚴重併髮癥髮生。隨訪6~36箇月,平均18箇月,患者腰痛癥狀消失。本組患者術後行B超、IVU檢查示腎盂輸尿管連接部吻閤口無梗阻;腎積水得到改善。結論:經腹入路腹腔鏡下離斷性腎盂成形術是治療UPJO的安全有效的微創手術方法。
목적:탐토경복입로복강경하신우성형술치료신우수뇨관련접부경조(UPJO)적수술방법급림상효과。방법:회고성분석2008년8월-2012년6월,대28례UPJO환자행경복입로복강경하리단성신우성형술적방법급효과。결과:28례환자균일차성수술성공,수술시간85~160 min,평균125 min;술중출혈량20~60 mL,평균32 mL;술후주원시간6~9 d,평균7.2 d;술후무엄중병발증발생。수방6~36개월,평균18개월,환자요통증상소실。본조환자술후행B초、IVU검사시신우수뇨관련접부문합구무경조;신적수득도개선。결론:경복입로복강경하리단성신우성형술시치료UPJO적안전유효적미창수술방법。
Objective:To evaluate the operation technique and clinical effects of transperitoneal laparoscopic pyeloplasty for ureteropelvic junction obstruction(UPJO). Method:28 cases with UPJO undergoing transperitoneal laparoscopic pyeloplasty were analyzed retrospectively. Result:All the operations were completed successfully. The operative time was 85 to 160 min,average 120 min. The blood loss was 20 to 60 mL,average 32 mL. The postoperative hospital stay was 6 to 9 d,an average of 7.2 d. No serious complication was found. Postoperative follow-up time was 6 to 36 months,an average of 18 months,the symptom of lumbodynia disappeared. There was no stricture at UPJ and hydronephrosis was remitted obviously in all patients. Conclusion:Transperitoneal laparoscopic pyeloplasty for UPJO is a effective,safe,minimally invasive surgical techniques.